Treatment Action Group Remembers Marvin Shulman
Treatment Action Group mourns the death of TAG’s founding treasurer Marvin Shulman (May 17, 1932–January 15, 2014), who died Wednesday in Miami Beach, Florida.
2013 TAG Update
TAG’s annual review of progress we’ve made on the the fight to end HIV/AIDS, Viral Hepatitis, and Tuberculosis.
TAG Applauds $12 Billion Replenishment of Global Fund to Fight AIDS, Tuberculosis and Malaria
Treatment Action Group applauds the donors who have helped make it possible to save more lives by raising a record-breaking $12 billion for the Global Fund to Fight AIDS, Tuberculosis and Malaria over the next three years. TAG also commends the Obama administration for its generous match of one dollar for every two dollars contributed by other donors, which helped to drive up funding commitments in the current replenishment round.
Filling the Gaps in the U.S. HIV Treatment Cascade: Developing a Community-Driven Research Agenda
Since the introduction of highly active antiretroviral therapy (ART) in 1996, the annual death rate from HIV/AIDS has dropped in the United States by over two-thirds. The U.S. Centers for Disease Control and Prevention estimates that approximately 1.2 million Americans are living with HIV.
amfAR and Treatment Action Group Call for a Strategic Research Agenda Needed to End HIV/AIDS in the United States
Today, on World AIDS Day, amfAR, The Foundation for AIDS Research, and Treatment Action Group (TAG) called for a deliberate and expedited research agenda designed to begin to end the AIDS epidemic in the United States. Both organizations noted that in order to achieve this goal, Congress must end sequestration and work to ensure the full implementation of the Affordable Care Act (ACA).
Letter to Secretary Sebelius on ACA Allowance of Drug Co-Pay Programs
167 Organizations and 513 Individuals Signed on to Letter to Secretary Sebelius on the Allowance of Co-pay Assistance in the ACA Health Plans
Training Manual for Treatment Advocates: Hepatitis C Virus and Coinfection with HIV
November 2013 By Karyn Kaplan and Tracy Swan The purpose of this manual is to provide information for you and your community. This information can be used to advocate for access to prevention and diagnosis of, and care and treatment…
Emerging Regulatory Issues in HIV Cure Research
The science of discovery comes with ethical challenges in human clinical trials By Richard Jefferys Over the past several years, there has been a welcome invigoration of the research effort to cure HIV infection. The mainstream media has picked up…
TAG’s Commitment to HIV Prevention
By Tim Horn Though the number of new HIV infections in the United States is down from its peak in the 1980s, incidence has refused to budge below its decade-long average: roughly 50,000 American residents are infected with the virus…